$TGAAF
Target Global Acquisition I Corp.

2024 Q3 Form 10-Q Financial Statement

#000119312524270192 Filed on December 04, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$1.608M
YoY Change 360.53%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$2.566M
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$4.174M
YoY Change -1609.17%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $5.693K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $22.75K
Receivables
Other Receivables
Total Short-Term Assets $28.44K
YoY Change -74.38%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $20.55M
YoY Change -57.83%
TOTAL ASSETS
Total Short-Term Assets $28.44K
Total Long-Term Assets $20.55M
Total Assets $20.58M
YoY Change -57.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.573M
YoY Change 69.23%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.573M
Total Long-Term Liabilities
Total Liabilities $3.573M
YoY Change -39.15%
SHAREHOLDERS EQUITY
Retained Earnings -$3.545M
YoY Change -62.77%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.545M
YoY Change
Total Liabilities & Shareholders Equity $20.58M
YoY Change -57.86%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$4.174M
YoY Change -1609.17%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001847355
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Entity Address Address Line3
EntityAddressAddressLine3
23 Lime Tree Bay Avenue
dei Entity Address Country
EntityAddressCountry
KY
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1608381
us-gaap Operating Income Loss
OperatingIncomeLoss
-1361327
CY2024Q3 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
32
CY2023Q3 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
0
us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
476574
CY2024Q3 tgaau Finance Cost
FinanceCost
2813549
tgaau Finance Cost
FinanceCost
2813549
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
247903
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
625818
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
TARGET GLOBAL ACQUISITION I CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity File Number
EntityFileNumber
001-41135
dei Entity Address Address Line1
EntityAddressAddressLine1
PO Box 10176
dei Entity Address Address Line2
EntityAddressAddressLine2
Governor’s Square
dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1102
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
796-4796
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 us-gaap Cash
Cash
5693
CY2023Q4 us-gaap Cash
Cash
4625
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
22749
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25750
CY2024Q3 us-gaap Assets Current
AssetsCurrent
28442
CY2023Q4 us-gaap Assets Current
AssetsCurrent
30375
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
20551207
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
43419605
CY2024Q3 us-gaap Assets
Assets
20579649
CY2023Q4 us-gaap Assets
Assets
43449980
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1721954
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
825683
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
548783
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
263951
CY2024Q3 tgaau Promissory Note Related Party Current
PromissoryNoteRelatedPartyCurrent
1302581
CY2023Q4 tgaau Promissory Note Related Party Current
PromissoryNoteRelatedPartyCurrent
2011015
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3573318
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3100649
CY2024Q3 tgaau Deferred Underwriting Commissions
DeferredUnderwritingCommissions
0
CY2023Q4 tgaau Deferred Underwriting Commissions
DeferredUnderwritingCommissions
3760690
CY2024Q3 us-gaap Liabilities
Liabilities
3573318
CY2023Q4 us-gaap Liabilities
Liabilities
6861339
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
20551207
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
43419605
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3545413
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6831501
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3544876
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6830964
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20579649
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43449980
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1608381
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
349242
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2407973
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1361327
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1608381
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-349242
us-gaap Operating Income Loss
OperatingIncomeLoss
-2407973
us-gaap Operating Income Loss
OperatingIncomeLoss
-1361327
CY2024Q3 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
32
CY2023Q3 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
0
us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
476574
CY2024Q3 tgaau Finance Cost
FinanceCost
2813549
tgaau Finance Cost
FinanceCost
2813549
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
247903
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
625818
us-gaap Investment Income Interest
InvestmentIncomeInterest
1204492
us-gaap Investment Income Interest
InvestmentIncomeInterest
5116755
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2565614
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
625818
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1132483
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5116755
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4173995
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
276576
us-gaap Net Income Loss
NetIncomeLoss
-3540456
us-gaap Net Income Loss
NetIncomeLoss
3755428
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6830964
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
824568
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-109698
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-7765230
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
657021
CY2024Q2 tgaau Adjustments To Additional Paid In Capital Waiver Of Deferred Underwriters Discount
AdjustmentsToAdditionalPaidInCapitalWaiverOfDeferredUnderwritersDiscount
3760690
CY2024Q2 tgaau Stockholders Equity Impact Of Change In Control Value
StockholdersEquityImpactOfChangeInControlValue
1867216
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2565614
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1132483
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5116755
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4173995
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
276576
us-gaap Net Income Loss
NetIncomeLoss
-3540456
us-gaap Net Income Loss
NetIncomeLoss
3755428
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6830964
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
824568
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-109698
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-7765230
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
657021
CY2024Q2 tgaau Adjustments To Additional Paid In Capital Waiver Of Deferred Underwriters Discount
AdjustmentsToAdditionalPaidInCapitalWaiverOfDeferredUnderwritersDiscount
3760690
CY2024Q2 tgaau Stockholders Equity Impact Of Change In Control Value
StockholdersEquityImpactOfChangeInControlValue
1867216
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
743237
CY2024Q3 tgaau Contribution From Previous Sponsor
ContributionFromPreviousSponsor
120388
CY2024Q2 tgaau Sponsor Equity Contribution
SponsorEquityContribution
2813549
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4173995
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3544876
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7800614
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2358022
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2105779
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4292167
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2402931
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1373073
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-5322024
us-gaap Net Income Loss
NetIncomeLoss
3755428
tgaau Finance Cost
FinanceCost
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
1204492
us-gaap Investment Income Interest
InvestmentIncomeInterest
5116755
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3001
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-70081
tgaau Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
896271
tgaau Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
426336
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-680763
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-774910
tgaau Payments To Extension Held In Trust Account
PaymentsToExtensionHeldInTrustAccount
530807
tgaau Payments To Extension Held In Trust Account
PaymentsToExtensionHeldInTrustAccount
360015
tgaau Cash Withdrawn From Trust Account For Stock Redemptions
CashWithdrawnFromTrustAccountForStockRedemptions
24603697
tgaau Cash Withdrawn From Trust Account For Stock Redemptions
CashWithdrawnFromTrustAccountForStockRedemptions
178982472
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24072890
tgaau Payment From Cash Withdrawn From Trust Account For Stock Redemptions
PaymentFromCashWithdrawnFromTrustAccountForStockRedemptions
178982472
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1092250
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
810015
tgaau Contribution From Previous Sponsor
ContributionFromPreviousSponsor
120388
tgaau Contribution From Previous Sponsor
ContributionFromPreviousSponsor
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23391059
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-178172457
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1068
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-324910
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4625
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
394251
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5693
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69341
tgaau Waiver Of Deferred Underwriters Discount
WaiverOfDeferredUnderwritersDiscount
3760690
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
743237
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-2051108
CY2024Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
253710
CY2024Q3 tgaau Contribution From Previous Sponsor
ContributionFromPreviousSponsor
120388
CY2024Q2 tgaau Sponsor Equity Contribution
SponsorEquityContribution
2813549
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2358022
CY2023Q1 tgaau Adjustments To Additional Paid In Capital Waiver Of Deferred Underwriters Discount
AdjustmentsToAdditionalPaidInCapitalWaiverOfDeferredUnderwritersDiscount
3760690
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2105779
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4292167
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2402931
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1373073
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-5322024
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
715818
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
276576
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5761266
us-gaap Net Income Loss
NetIncomeLoss
-3540456
us-gaap Net Income Loss
NetIncomeLoss
3755428
tgaau Finance Cost
FinanceCost
2813549
tgaau Finance Cost
FinanceCost
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
1204492
us-gaap Investment Income Interest
InvestmentIncomeInterest
5116755
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3001
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-70081
tgaau Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
896271
tgaau Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
426336
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
351364
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
90000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-680763
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-774910
tgaau Payments To Extension Held In Trust Account
PaymentsToExtensionHeldInTrustAccount
530807
tgaau Payments To Extension Held In Trust Account
PaymentsToExtensionHeldInTrustAccount
360015
tgaau Cash Withdrawn From Trust Account For Stock Redemptions
CashWithdrawnFromTrustAccountForStockRedemptions
24603697
tgaau Cash Withdrawn From Trust Account For Stock Redemptions
CashWithdrawnFromTrustAccountForStockRedemptions
178982472
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24072890
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
178622457
tgaau Payment From Cash Withdrawn From Trust Account For Stock Redemptions
PaymentFromCashWithdrawnFromTrustAccountForStockRedemptions
24603697
tgaau Payment From Cash Withdrawn From Trust Account For Stock Redemptions
PaymentFromCashWithdrawnFromTrustAccountForStockRedemptions
178982472
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1092250
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
810015
tgaau Contribution From Previous Sponsor
ContributionFromPreviousSponsor
120388
tgaau Contribution From Previous Sponsor
ContributionFromPreviousSponsor
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23391059
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-178172457
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1068
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-324910
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4625
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
394251
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5693
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69341
tgaau Waiver Of Deferred Underwriters Discount
WaiverOfDeferredUnderwritersDiscount
3760690
tgaau Waiver Of Deferred Underwriters Discount
WaiverOfDeferredUnderwritersDiscount
3760690
tgaau Impact Of Change In Control Stockholders Equity
ImpactOfChangeInControlStockholdersEquity
1867216
tgaau Impact Of Change In Control Stockholders Equity
ImpactOfChangeInControlStockholdersEquity
0
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1735299
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
5476770
tgaau Waiver Of Deferred Underwriters Discount
WaiverOfDeferredUnderwritersDiscount
3760690
tgaau Impact Of Change In Control Stockholders Equity
ImpactOfChangeInControlStockholdersEquity
1867216
tgaau Impact Of Change In Control Stockholders Equity
ImpactOfChangeInControlStockholdersEquity
0
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1735299
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
5476770
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-02-02
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14896580
CY2024Q3 tgaau Percentage Of Amount Of Trust Assets Of Target Company Excluding Underwriting Commission Working Capital And Taxes
PercentageOfAmountOfTrustAssetsOfTargetCompanyExcludingUnderwritingCommissionWorkingCapitalAndTaxes
0.80
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.2
CY2024Q3 tgaau Interest Income On Trust Account To Be Set Aside To Pay Dissolution Expenses
InterestIncomeOnTrustAccountToBeSetAsideToPayDissolutionExpenses
100000
CY2024Q3 tgaau Interest Income On Trust Account To Be Set Aside To Pay Dissolution Expenses
InterestIncomeOnTrustAccountToBeSetAsideToPayDissolutionExpenses
100000
CY2024Q3 tgaau Estimated Amount Of Assets To Remain In Trust Account Post Redemption
EstimatedAmountOfAssetsToRemainInTrustAccountPostRedemption
20350872
CY2024Q3 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
90000
tgaau Extended Period On Or Before Which Business Combination Shall Be Consummated
ExtendedPeriodOnOrBeforeWhichBusinessCombinationShallBeConsummated
P24M
CY2024Q2 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
90000
CY2024Q2 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
90000
CY2024Q3 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
90000
CY2024Q3 tgaau Estimated Amount Of Assets To Remain In Trust Account Post Redemption
EstimatedAmountOfAssetsToRemainInTrustAccountPostRedemption
20350872
CY2024Q3 tgaau Cash Outside The Trust Account
CashOutsideTheTrustAccount
5693
CY2024Q3 tgaau Working Capital Deficit
WorkingCapitalDeficit
3544876
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
2038250
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
1065015
tgaau Redeemable Percentage Of Outstanding Public Shares
RedeemablePercentageOfOutstandingPublicShares
1
CY2024Q3 tgaau Interest Income On Trust Account To Be Set Aside To Pay Dissolution Expenses
InterestIncomeOnTrustAccountToBeSetAsideToPayDissolutionExpenses
100000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-02-02
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14896580
CY2024Q3 tgaau Percentage Of Amount Of Trust Assets Of Target Company Excluding Underwriting Commission Working Capital And Taxes
PercentageOfAmountOfTrustAssetsOfTargetCompanyExcludingUnderwritingCommissionWorkingCapitalAndTaxes
0.80
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.2
CY2024Q3 tgaau Interest Income On Trust Account To Be Set Aside To Pay Dissolution Expenses
InterestIncomeOnTrustAccountToBeSetAsideToPayDissolutionExpenses
100000
CY2024Q3 tgaau Interest Income On Trust Account To Be Set Aside To Pay Dissolution Expenses
InterestIncomeOnTrustAccountToBeSetAsideToPayDissolutionExpenses
100000
CY2024Q3 tgaau Estimated Amount Of Assets To Remain In Trust Account Post Redemption
EstimatedAmountOfAssetsToRemainInTrustAccountPostRedemption
20350872
CY2024Q3 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
90000
tgaau Extended Period On Or Before Which Business Combination Shall Be Consummated
ExtendedPeriodOnOrBeforeWhichBusinessCombinationShallBeConsummated
P24M
CY2024Q2 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
90000
CY2024Q2 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
90000
CY2024Q3 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
90000
CY2024Q3 tgaau Estimated Amount Of Assets To Remain In Trust Account Post Redemption
EstimatedAmountOfAssetsToRemainInTrustAccountPostRedemption
20350872
CY2024Q3 tgaau Working Capital Deficit
WorkingCapitalDeficit
3544876
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
2038250
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
1065015
tgaau Redeemable Percentage Of Outstanding Public Shares
RedeemablePercentageOfOutstandingPublicShares
1
CY2024Q3 tgaau Interest Income On Trust Account To Be Set Aside To Pay Dissolution Expenses
InterestIncomeOnTrustAccountToBeSetAsideToPayDissolutionExpenses
100000
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of unaudited condensed financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could <div style="display:inline;">differ </div>significantly from those estimates. </div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of unaudited condensed financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could <div style="display:inline;">differ </div>significantly from those estimates. </div>
CY2024Q3 us-gaap Cash
Cash
5693
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
20551207
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
43419605
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2024Q3 us-gaap Cash
Cash
5693
CY2023Q4 us-gaap Cash
Cash
4625
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
20551207
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
43419605
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023 tgaau Redemption Of Shares
RedemptionOfShares
-185164838
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
6349758
tgaau Redemption Of Shares
RedemptionOfShares
-24603697
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1735299
CY2023 tgaau Redemption Of Shares
RedemptionOfShares
-185164838
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
6349758
tgaau Redemption Of Shares
RedemptionOfShares
-24603697
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1735299
CY2024Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2021Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
219194512
CY2021Q1 tgaau Percentage Of Shares Issuable Upon Conversion
PercentageOfSharesIssuableUponConversion
50
CY2021Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
500000
CY2023 tgaau Offering Proceeds Allocated To Offering Expenses
OfferingProceedsAllocatedToOfferingExpenses
1000000
CY2024Q2 tgaau Amount Waived By The Company In Respect Of Withdrawal From The Trust Account
AmountWaivedByTheCompanyInRespectOfWithdrawalFromTheTrustAccount
100000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
tgaau Number Of Days After Consummation Of Business Combination Within Which The Securities Shall Be Registered
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichTheSecuritiesShallBeRegistered
P20D
tgaau Number Of Days After Which Business Combination Within Which Securities Registration Shall Be Effective
NumberOfDaysAfterWhichBusinessCombinationWithinWhichSecuritiesRegistrationShallBeEffective
P60D
CY2023Q4 tgaau Class Of Warrants And Rights Issued During The Period
ClassOfWarrantsAndRightsIssuedDuringThePeriod
14227128
CY2024Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2021Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
219194512
CY2021Q1 tgaau Percentage Of Shares Issuable Upon Conversion
PercentageOfSharesIssuableUponConversion
50
CY2021Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
500000
CY2023 tgaau Offering Proceeds Allocated To Offering Expenses
OfferingProceedsAllocatedToOfferingExpenses
1000000
CY2024Q2 tgaau Amount Waived By The Company In Respect Of Withdrawal From The Trust Account
AmountWaivedByTheCompanyInRespectOfWithdrawalFromTheTrustAccount
100000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
tgaau Number Of Days After Consummation Of Business Combination Within Which The Securities Shall Be Registered
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichTheSecuritiesShallBeRegistered
P20D
tgaau Number Of Days After Which Business Combination Within Which Securities Registration Shall Be Effective
NumberOfDaysAfterWhichBusinessCombinationWithinWhichSecuritiesRegistrationShallBeEffective
P60D
CY2023Q4 tgaau Class Of Warrants And Rights Issued During The Period
ClassOfWarrantsAndRightsIssuedDuringThePeriod
14227128
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
20551207
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
43419605
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
20551207
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
43419605

Files In Submission

Name View Source Status
0001193125-24-270192-index-headers.html Edgar Link pending
0001193125-24-270192-index.html Edgar Link pending
0001193125-24-270192.txt Edgar Link pending
0001193125-24-270192-xbrl.zip Edgar Link pending
d862657d10q.htm Edgar Link pending
d862657dex311.htm Edgar Link pending
d862657dex312.htm Edgar Link pending
d862657dex321.htm Edgar Link pending
d862657dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d862657d10q_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tgaau-20240930.xsd Edgar Link pending
tgaau-20240930_def.xml Edgar Link unprocessable
tgaau-20240930_lab.xml Edgar Link unprocessable
tgaau-20240930_pre.xml Edgar Link unprocessable
tgaau-20240930_cal.xml Edgar Link unprocessable